top of page

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Bart Schade
May 9, 2024
1 min read

Read the full press release here.

Recent Posts

Field Medical Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Field Medical Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

First-in-Human VCAS Trial Results with FieldForce™ Ablation System Published in Circulation

First-in-Human VCAS Trial Results with FieldForce™ Ablation System Published in Circulation

Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden

Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.

bottom of page